IL-12 elispot assays to detect and enumerate IL-12 secreting cells

Area of Science:

• Immunology
• Cellular Biology
• Biotechnology

Background:

• Interleukin-12 (IL-12) is crucial for Th1 immune responses and immune regulation.
• Detecting IL-12 has been challenging due to its complex nature and the need for stimulants.
• IL-12 is a potential target for immunotherapy in inflammation and autoimmune diseases.

Purpose of the Study:

• To develop and validate enzyme-linked immunospot (ELISPOT) assays for detecting IL-12 p40 secreting cells.
• To enumerate IL-12 p40 secreting cells in healthy individuals without in vitro stimulation.
• To compare ELISPOT results with intracellular staining by flow cytometry.

Main Methods:

• Development of IL-12 p40-specific ELISPOT assays.
• Enumeration of IL-12 p40 secreting cells in peripheral blood mononuclear cells (MNCs) from healthy subjects.
• Intracellular staining for IL-12 p40 using flow cytometry for comparative analysis.
• Stimulation assays using bacterial endotoxins (LPS) and inflammatory cytokines (TNF-alpha, IFN-gamma).

Main Results:

• IL-12 p40 secreting cells were detected in healthy subjects (mean 103+/-155 per 10^5 MNCs).
• ELISPOT results correlated significantly with flow cytometry findings.
• ELISPOT assays confirmed elevated IL-12 p40 secreting MNCs upon stimulation with TNF-alpha, IFN-gamma, LPS, or combinations thereof.
• The assays demonstrated sensitivity, specificity, and reliability.

Conclusions:

• IL-12 p40 ELISPOT assays provide a sensitive, specific, and reliable method for enumerating IL-12 p40 secreting cells.
• This technique allows for the detection of IL-12 p40 secreting cells without prior in vitro stimulation.
• The developed ELISPOT assays are valuable tools for studying IL-12's role in health and disease, particularly in inflammation and autoimmunity.